GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC

Johns Hopkins Hospital, Baltimore, Maryland, United States

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Auckland Clinical Studies, Auckland, New Zealand